Skip to main content
. 2022 Nov;3(11):e754–e776. doi: 10.1016/S2666-7568(22)00213-6

Figure 3.

Figure 3

Global distribution of benign prostatic hyperplasia burden in 2019

(A) Age-standardised prevalence per 100 000. (B) Age-standardised rate of disability-adjusted life-years (DALYs) per 100 000.